Based in Boston, Ryan joined C&EN in 2017 to cover the biotech and pharmaceutical industries. He previously studied neuroscience and genetics at Purdue University, and earned an M.S. in science journalism at Boston University. He writes news and feature stories about the scientists, startups, and drug companies trying to turn the latest biomedical discoveries into medicines. He is particularly interested in bioethics, CRISPR, genetic engineering, neuropharmacology, new drug modalities, and emerging scientific fields.